Rotational therapy with TNF-α blockers for recalcitrant hidradenitis suppurativa

European Journal of Dermatology

Volumn 20, Issue 5, 2010, Pages 644-646

  Brunasso, Alexandra Maria Giovanna ^a   Massone, Cesare ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; CASE REPORT; DISEASE DURATION; DISEASE SEVERITY; HUMAN; LETTER; MALE; QUALITY OF LIFE; RELAPSE; SUPPURATIVE HIDRADENITIS; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; HIDRADENITIS SUPPURATIVA; HUMANS; IMMUNOGLOBULIN G; MALE; PAIN MEASUREMENT; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956896354     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.1037     Document Type: Letter

References (6)

1. Revuz J. Hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2009; 23: 985-98.
2. Brunasso AM, Delfino C, Massone C. Hidradenitis suppurativa: are tumour necrosis factor-alpha blockers the ultimate alternative? Br J Dermatol 2008; 159: 761-3.
3. Aarden L, Ruuls SR, Wolbink G. Immunogenicity of anti-tumor necrosis factor antibodies-toward improved methods of anti-antibody measurement. Curr Opin Immunol 2008; 20: 431-5.
4. Fardet L. Dupuy A, kerob D, et al. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients. J Am Acad Dermatol 2007; 56: 624-8. (Pubitemid 46400174)
5. Poulin Y. Successful treatment of hidradenitis suppurativa with infliximab in a patient who failed to respond to etanercept. J Cutan Med Surg 2009; 13: 221-5.
6. Barde C, Thielen AM, Kuenzli S, et al. Treatment of plaque psoriasis by sequential therapy with two 'biologics': the 'hit and run' approach, a report of two cases. Br J Dermatol 2006; 155: 211-3.